EHI
NTRA icon

Eagle Health Investments’s Natera NTRA Stock Holding History

Eagle Health Investments’s Portfolio NTRA Stock Details NTRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4M Sell
121,877
-61,387
-33% -$13.2M 4.26% 7
2025
Q4 		$42M Sell
183,264
-20,400
-10% -$4.26M 9.23% 3
2025
Q3 		$32.8M Sell
203,664
-32,300
-14% -$5.11M 8.61% 3
2025
Q2 		$39.9M Sell
235,964
-43,800
-16% -$6.83M 9.84% 3
2025
Q1 		$39.6M Sell
279,764
-60,000
-18% -$9.64M 10.27% 2
2024
Q4 		$53.8M Sell
339,764
-91,550
-21% -$13.3M 13.19% 1
2024
Q3 		$54.8M Sell
431,314
-42,800
-9% -$4.91M 10.37% 1
2024
Q2 		$51.3M Sell
474,114
-158,600
-25% -$16.1M 9% 2
2024
Q1 		$57.9M Sell
632,714
-58,148
-8% -$4.37M 10.75% 1
2023
Q4 		$43.3M Buy
690,862
+95,168
+16% +$4.75M 8.79% 3
2023
Q3 		$26.4M Hold
595,694
– – 5.81% 7
2023
Q2 		$29M Sell
595,694
-189,200
-24% -$9.65M 5.42% 7
2023
Q1 		$43.6M Sell
784,894
-30,100
-4% -$1.44M 8.48% 3
2022
Q4 		$32.7M Buy
814,994
+219,000
+37% +$9.02M 7.55% 4
2022
Q3 		$26.1M Buy
595,994
+25,000
+4% +$1.19M 5.99% 6
2022
Q2 		$20.2M Buy
570,994
+123,500
+28% +$4.57M 4.72% 9
2022
Q1 		$18.2M Buy
447,494
+235,800
+111% +$14.2M 4.49% 12
2021
Q4 		$19.8M Buy
211,694
+47,200
+29% +$4.9M 4.82% 8
2021
Q3 		$18.3M Buy
164,494
+1,300
+0.8% +$149K 5.81% 4
2021
Q2 		$18.5M Sell
163,194
-5,200
-3% -$532K 6.36% 4
2021
Q1 		$17.1M Buy
168,394
+89,794
+114% +$9.84M 6.71% 6
2020
Q4 		$7.82M Buy
+78,600
New +$6.57M 5% 9

Other funds holding NTRA

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Health Investments's NTRA Position: Q1 2026 in Review

Eagle Health Investments reduced its Natera (NTRA) stake by 33% in Q1 2026, selling an estimated $13.2M and leaving 121,877 shares worth $24.4M. The position accounts for 4.26% of the portfolio, ranked #7.

Eagle Health Investments first reported a position in NTRA in Q4 2020 and has held it in 22 quarters since. The position peaked at $57.9M in Q1 2024. 762 funds tracked by Wall St. Rank hold NTRA as of Q1 2026.

  • Eagle Health Investments held 121,877 shares of Natera worth $24.4M as of Q1 2026.
  • Eagle Health Investments sold 61,387 Natera shares in Q1 2026, an estimated $13.2M.
  • Natera made up 4.26% of Eagle Health Investments's portfolio in Q1 2026, its #7 holding.
  • Eagle Health Investments first reported a position in Natera in Q4 2020 and has held it in 22 quarters since.
  • Eagle Health Investments's Natera position peaked at $57.9M in Q1 2024.
  • 762 funds tracked by Wall St. Rank held Natera as of Q1 2026.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.